SCHEMBL4745862

SCHEMBL4745862

N#Cc1ccc(CC(N)c2ccc(O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.53
CA2 P00918 1/20 0.53
CA3 P07451 1/20 0.53
CA6 P23280 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
ESR1 P03372 6/20 0.53
ESR2 Q92731 6/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
KMT2A Q03164 1/20 0.53
CYP19A1 P11511 2/20 0.52
MMP3 P08254 1/20 0.48
TAAR1 Q96RJ0 3/20 0.46
SLC6A2 P23975 1/20 0.46
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5332232 0.86 TAAR1 (0.59) ESR1ESR2CYP1A2CYP2C19MEN1
SCHEMBL17253753 0.83 MAOB (0.47) CYP1A2CYP2C19CYP19A1TAAR1SLC6A2
SCHEMBL4749300 0.81 LOXL2 (0.43) CA12CA2CA3CA6CA9
SCHEMBL4749835 0.81 FOLH1 (0.44) CA12CA2CA3CA6CA9
SCHEMBL7042096 0.77 TAAR1 (0.50) ESR1ESR2CYP1A2CYP2C19MEN1
SCHEMBL378138 0.77 EPHX1 (0.50) ESR1ESR2CYP1A2CYP2C19TAAR1
SCHEMBL3917628 0.77 TAAR1 (0.53) ESR1ESR2CYP1A2CYP2C19TAAR1
SCHEMBL17277081 0.76 TAAR1 (0.57) ESR1ESR2CYP1A2CYP2C19MEN1
SCHEMBL7359666 0.75 LOXL2 (0.47) LOXL2
SCHEMBL7359657 0.75 SLC6A2 (0.46) MEN1ALDH1A1KMT2ACYP19A1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 WO claimed
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 WO disclosed